Your browser doesn't support javascript.
SARS-CoV-2 persistence in immunocompromised children.
Dolan, Susan A; Mulcahy Levy, Jean; Moss, Angela; Pearce, Kelly; Butler, Molly; Jung, Sarah; Dominguez, Samuel R; Mwangi, Eric; Maloney, Kelly; Rao, Suchitra.
  • Dolan SA; Department of Epidemiology, Children's Hospital Colorado, Aurora, Colorado, USA.
  • Mulcahy Levy J; Department of Pediatrics (Center for Cancer and Blood Disorders), University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, Colorado, USA.
  • Moss A; Morgan Adams Foundation Pediatric Brain Tumor Research Program, Children's Hospital Colorado, Aurora, Colorado, USA.
  • Pearce K; Department of Pharmacology, University of Colorado School of Medicine, Aurora, Colorado, USA.
  • Butler M; Children's Hospital Colorado and Adult and Child Center for Health Outcomes Research and Delivery Science, University of Colorado School of Medicine, Aurora, Colorado, USA.
  • Jung S; Department of Epidemiology, Children's Hospital Colorado, Aurora, Colorado, USA.
  • Dominguez SR; Department of Pathology and Laboratory Medicine, Children's Hospital Colorado, Aurora, Colorado, USA.
  • Mwangi E; Department of Pathology and Laboratory Medicine, Children's Hospital Colorado, Aurora, Colorado, USA.
  • Maloney K; Department of Pediatrics (Infectious Diseases), University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, Colorado, USA.
  • Rao S; Department of Pathology and Laboratory Medicine, Children's Hospital Colorado, Aurora, Colorado, USA.
Pediatr Blood Cancer ; 68(12): e29277, 2021 12.
Article in English | MEDLINE | ID: covidwho-1372767
ABSTRACT

OBJECTIVES:

We evaluated the length of time immunocompromised children (ICC) remain positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), identified factors associated with viral persistence, and determined cycle threshold (CT ) values of children with viral persistence as a surrogate of viral load.

METHODS:

We conducted a retrospective cohort study of ICC at a pediatric hospital from March 2020 to March 2021. Immunocompromised status was defined as primary, secondary, or acquired due to medical comorbidities/immunosuppressive treatment. The primary outcome was time to first of two consecutive negative SARS-CoV-2 polymerase chain reaction (PCR) tests at least 24 hours apart. Testing of sequential clinical specimens from the same subject was conducted using the Centers for Disease Control (CDC) 2019-nCoV real-time reverse transcriptase (RT)-PCR Diagnostic Panel assay. Descriptive statistics, Kaplan-Meier curve median event times and log-rank tests were used to compare outcomes between groups.

RESULTS:

Ninety-one children met inclusion criteria. Median age was 15.5 years (interquartile range [IQR] 8-18), 64% were male, 58% were White, and 43% were Hispanic/Latinx. Most (67%) were tested in outpatient settings and 58% were asymptomatic. The median time to two negative tests was 42 days (IQR 25.0-55.0), with no differences in median time by illness presentation or level of immunosuppression. Seven children had more than one sample available for repeat testing, and five of seven (71%) children had initial CT values of <30 (moderate to high viral load); four children had CT values of <30, 3-4 weeks later, suggesting persistent moderate to high viral loads.

CONCLUSIONS:

Most ICC with SARS-CoV-2 infection had mild disease, with prolonged viral persistence >6 weeks and moderate to high viral load.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunocompromised Host / COVID-19 Type of study: Cohort study / Diagnostic study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Adolescent / Child / Child, preschool / Humans / Male Language: English Journal: Pediatr Blood Cancer Journal subject: Hematology / Neoplasms / Pediatrics Year: 2021 Document Type: Article Affiliation country: Pbc.29277

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunocompromised Host / COVID-19 Type of study: Cohort study / Diagnostic study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Adolescent / Child / Child, preschool / Humans / Male Language: English Journal: Pediatr Blood Cancer Journal subject: Hematology / Neoplasms / Pediatrics Year: 2021 Document Type: Article Affiliation country: Pbc.29277